PET Imaging in Patients with Meningioma - Report of the RANO/PET Group. Galldiks, N., Albert, N. L., Sommerauer, M., Grosu, A. L., Ganswindt, U., Law, I., Preusser, M., Le Rhun, E., Vogelbaum, M. A., Zadeh, G., Dhermain, F., Weller, M., Langen, K. J., & Tonn, J. C. Neuro Oncol, 2017. ![PET Imaging in Patients with Meningioma - Report of the RANO/PET Group [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Meningiomas are the most frequent non-glial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly magnetic resonance imaging (MRI) or rarely computed tomography (CT). Most common treatment options are neurosurgical resection and radiotherapy, e.g., radiosurgery or external fractionated radiotherapy. For follow-up after treatment, structural imaging techniques such as MRI or CT are used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as positron emission tomography (PET) can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.
@article{galldiks_pet_2017,
title = {{PET} {Imaging} in {Patients} with {Meningioma} - {Report} of the {RANO}/{PET} {Group}},
issn = {1523-5866 (Electronic) 1522-8517 (Linking)},
url = {http://www.ncbi.nlm.nih.gov/pubmed/28605532},
doi = {10.1093/neuonc/nox112},
abstract = {Meningiomas are the most frequent non-glial primary brain tumors and represent about 30\% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly magnetic resonance imaging (MRI) or rarely computed tomography (CT). Most common treatment options are neurosurgical resection and radiotherapy, e.g., radiosurgery or external fractionated radiotherapy. For follow-up after treatment, structural imaging techniques such as MRI or CT are used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as positron emission tomography (PET) can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.},
journal = {Neuro Oncol},
author = {Galldiks, N. and Albert, N. L. and Sommerauer, M. and Grosu, A. L. and Ganswindt, U. and Law, I. and Preusser, M. and Le Rhun, E. and Vogelbaum, M. A. and Zadeh, G. and Dhermain, F. and Weller, M. and Langen, K. J. and Tonn, J. C.},
year = {2017},
}
Downloads: 0
{"_id":"aSMrgw96AW58QuhaX","bibbaseid":"galldiks-albert-sommerauer-grosu-ganswindt-law-preusser-lerhun-etal-petimaginginpatientswithmeningiomareportoftheranopetgroup-2017","downloads":0,"creationDate":"2019-03-25T15:04:28.351Z","title":"PET Imaging in Patients with Meningioma - Report of the RANO/PET Group","author_short":["Galldiks, N.","Albert, N. L.","Sommerauer, M.","Grosu, A. L.","Ganswindt, U.","Law, I.","Preusser, M.","Le Rhun, E.","Vogelbaum, M. A.","Zadeh, G.","Dhermain, F.","Weller, M.","Langen, K. J.","Tonn, J. C."],"year":2017,"bibtype":"article","biburl":"https://api.zotero.org/users/4915350/collections/YPPRWHHG/items?key=9UQuiwltMdY02lUFuEAB0dvL&format=bibtex&limit=100","bibdata":{"bibtype":"article","type":"article","title":"PET Imaging in Patients with Meningioma - Report of the RANO/PET Group","issn":"1523-5866 (Electronic) 1522-8517 (Linking)","url":"http://www.ncbi.nlm.nih.gov/pubmed/28605532","doi":"10.1093/neuonc/nox112","abstract":"Meningiomas are the most frequent non-glial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly magnetic resonance imaging (MRI) or rarely computed tomography (CT). Most common treatment options are neurosurgical resection and radiotherapy, e.g., radiosurgery or external fractionated radiotherapy. For follow-up after treatment, structural imaging techniques such as MRI or CT are used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as positron emission tomography (PET) can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.","journal":"Neuro Oncol","author":[{"propositions":[],"lastnames":["Galldiks"],"firstnames":["N."],"suffixes":[]},{"propositions":[],"lastnames":["Albert"],"firstnames":["N.","L."],"suffixes":[]},{"propositions":[],"lastnames":["Sommerauer"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Grosu"],"firstnames":["A.","L."],"suffixes":[]},{"propositions":[],"lastnames":["Ganswindt"],"firstnames":["U."],"suffixes":[]},{"propositions":[],"lastnames":["Law"],"firstnames":["I."],"suffixes":[]},{"propositions":[],"lastnames":["Preusser"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Le","Rhun"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Vogelbaum"],"firstnames":["M.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Zadeh"],"firstnames":["G."],"suffixes":[]},{"propositions":[],"lastnames":["Dhermain"],"firstnames":["F."],"suffixes":[]},{"propositions":[],"lastnames":["Weller"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Langen"],"firstnames":["K.","J."],"suffixes":[]},{"propositions":[],"lastnames":["Tonn"],"firstnames":["J.","C."],"suffixes":[]}],"year":"2017","bibtex":"@article{galldiks_pet_2017,\n\ttitle = {{PET} {Imaging} in {Patients} with {Meningioma} - {Report} of the {RANO}/{PET} {Group}},\n\tissn = {1523-5866 (Electronic) 1522-8517 (Linking)},\n\turl = {http://www.ncbi.nlm.nih.gov/pubmed/28605532},\n\tdoi = {10.1093/neuonc/nox112},\n\tabstract = {Meningiomas are the most frequent non-glial primary brain tumors and represent about 30\\% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly magnetic resonance imaging (MRI) or rarely computed tomography (CT). Most common treatment options are neurosurgical resection and radiotherapy, e.g., radiosurgery or external fractionated radiotherapy. For follow-up after treatment, structural imaging techniques such as MRI or CT are used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as positron emission tomography (PET) can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.},\n\tjournal = {Neuro Oncol},\n\tauthor = {Galldiks, N. and Albert, N. L. and Sommerauer, M. and Grosu, A. L. and Ganswindt, U. and Law, I. and Preusser, M. and Le Rhun, E. and Vogelbaum, M. A. and Zadeh, G. and Dhermain, F. and Weller, M. and Langen, K. J. and Tonn, J. C.},\n\tyear = {2017},\n}\n\n","author_short":["Galldiks, N.","Albert, N. L.","Sommerauer, M.","Grosu, A. L.","Ganswindt, U.","Law, I.","Preusser, M.","Le Rhun, E.","Vogelbaum, M. A.","Zadeh, G.","Dhermain, F.","Weller, M.","Langen, K. J.","Tonn, J. C."],"key":"galldiks_pet_2017","id":"galldiks_pet_2017","bibbaseid":"galldiks-albert-sommerauer-grosu-ganswindt-law-preusser-lerhun-etal-petimaginginpatientswithmeningiomareportoftheranopetgroup-2017","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/28605532"},"downloads":0},"search_terms":["pet","imaging","patients","meningioma","report","rano","pet","group","galldiks","albert","sommerauer","grosu","ganswindt","law","preusser","le rhun","vogelbaum","zadeh","dhermain","weller","langen","tonn"],"keywords":[],"authorIDs":[],"dataSources":["nujP43M5eTb6b6trn"]}